|
TRAF6 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.87627691161651E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.989790E-01 |
| Stage1-vs-Stage3 |
8.064600E-03 |
| Stage1-vs-Stage4 |
5.75919999999952E-05 |
| Stage2-vs-Stage3 |
2.641500E-03 |
| Stage2-vs-Stage4 |
1.011350E-04 |
| Stage3-vs-Stage4 |
1.585400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.77699965853151E-10 |
| Normal-vs-Asian |
1.62470037423645E-12 |
| Caucasian-vs-AfricanAmerican |
4.433600E-01 |
| Caucasian-vs-Asian |
2.591000E-01 |
| AfricanAmerican-vs-Asian |
9.562400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.371000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.03799999995324E-06 |
| Classical-VS-Follicular |
3.213800E-02 |
| Classical-VS-Other |
2.873800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
7.53869999758905E-08 |
| Tall-VS-Other |
3.597800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.317350E-01 |
| Follicular-VS-Normal |
1.64501745558709E-12 |
| Other-VS-Normal |
2.13400000004249E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
9.736200E-03 |
|
|
